NSTK: Message Board for Nastech Pharmaceutical Company Inc. | Forum profile

Class act. Please check PM. msg 14936

microRNA Research Design: Strategies from the Experts Tuesday, November 10, 2009 - noon Eastern, 9 a.m. Pacific, 5 p.m. GMT MicroRNAs, or miRNAs, are increasingly being accepted as playing a crucial regulatory role in normal and dysfunctional cellular processes. They represent a class of small, noncoding RNA molecules, which have been shown to be involved in almost every human pathology currently under study. From tumor progression and viral...

I believe PAR reports on Friday. What are the chances that we will hear about sales of Calcitonin since its release. We get a small piece of that pie, right? Getting more than a little nervous about how mrna is going to pay the phone bill. msg ' + item.replyToNumber + '

If they are going the financing route, the proceedings must have already started with only about 2 months worth of cash management is prudent enough to be working on financing, remember their new CFO has experience in raising $$ in the biotechs space. At the same time if they are close enough to a partnership which would provide non-dilutive financing, clearly that is the more desirable route. In their conference calls they have indicated both...

oh msg 14940

I think they will address Calcitonin revenues, because there was expectation of it being a decent revenue generator.   With respect to the company's fixed expenses, I think we need to recalibrate the burn rate as a result of the sublease to AVII which is either substantially or entirely out of the 3Q numbers.   Combine that with the prospect of more traffic through the labs that required the hiring of a traffic cop...